OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase I Evaluation of a Fully Human Anti–αv Integrin Monoclonal Antibody (CNTO 95) in Patients with Advanced Solid Tumors

HTML

Year: 2007
Type: article
Study design: Clinical Trial
Source: Clinical Cancer Research
DOI: 10.1158/1078-0432.ccr-06-2779
Authors: Saifee A. Mullamitha, Nhuan C. Ton, Geoff J.M. Parker, Alan Jackson, Peter J. Julyan, Caleb Roberts, Gio A. Buonaccorsi, Yvonne Watson, Karen Davies, Sue Cheung, Lynn Hope, Juan W. Valle, John A. Radford, Jeremy Lawrance, Mark P. Saunders, Mihaela C. Munteanu, Marian T. Nakada, Jeffrey A. Nemeth, Hugh M. Davis, Qun Jiao, Uma Prabhakar, Zhihui Lang, Robert E. Corringham, Robert A. Beckman, Gordon C. Jayson
Institutions: Cancer Research UK, Cancer Research UK Cambridge Center, University of Manchester
Language: English

Topic: Cell Adhesion Molecules Research
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Keywords: ITGAV, angiogenesis inhibition, advanced solid tumors, refractory cancer, safety and tolerability, pharmacokinetics, cutaneous angiosarcoma, ovarian carcinosarcoma, tumor penetration, Bcl-2 expression, pharmacodynamic activity, extended dosing
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2057067749
FWCI: 9.737
Cites: 45
Cited by: 157
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security